UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) December 10, 2018
NORDSTROM, INC.
(Exact name of registrant as specified in its charter)
Washington | 001-15059 | 91-0515058 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||
1617 Sixth Avenue, Seattle, Washington | 98101 | |
(Address of principal executive offices) | (Zip Code) | |
Registrant's telephone number, including area code (206) 628-2111
Inapplicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
___ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
___ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
___ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
___ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
ITEM 8.01 Other Events
On December 10, 2018, Blake W. Nordstrom, Co-President of Nordstrom, Inc., issued a message to employees, customers and shareholders informing them of a recent medical diagnosis. A copy of his message is attached as Exhibit 99.1 and is incorporated herein by reference.
ITEM 9.01 Financial Statements and Exhibits
Message from Blake W. Nordstrom, Co-President of Nordstrom, Inc. | ||
EXHIBIT INDEX | ||
EXHIBIT | ||
NUMBER | DESCRIPTION | |
Message from Blake W. Nordstrom, Co-President of Nordstrom, Inc. | ||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NORDSTROM, INC. | |
(Registrant) | |
/s/ Robert B. Sari | |
Robert B. Sari | |
Senior Vice President, | |
General Counsel and Corporate Secretary | |
Date: December 10, 2018
Exhibit 99.1
A MESSAGE FROM BLAKE NORDSTROM
December 10, 2018
To our employees, customers and shareholders,
I want to share with all of you that I was diagnosed last week with lymphoma. Fortunately, my form of lymphoma is treatable. My doctors and I are optimistic and encouraged by my prognosis.
I will undergo chemotherapy over the next few months in Seattle and will reduce my scheduled travel during this time. As I focus on my health and knowing some days will be better than others, I’m told I can otherwise continue to work throughout this process as normal.
I have shared this news with our Executive Team and Board of Directors and I am thankful for their support. We have an outstanding team at Nordstrom and I’m also fortunate to share the co-presidency with my brothers, Pete and Erik.
Cancer is all too common, and I know many of you have dealt with it yourselves or know someone who has. I have a good team of doctors and value the support of my family and friends.
Both personally and professionally, I am confident in the path forward. On behalf of myself and my family, thank you in advance for your well wishes and support.
Blake
# # #